Mounjaro®
Starting from £179.99/mo
Start journey Learn moreGetting prescribed Wegovy in the UK means going through a clinical assessment with a prescriber who can determine whether you meet the licensed criteria. Wegovy (semaglutide 2.4mg and above) is a prescription-only medicine — a prescriber, not a website checkout, decides your suitability. The assessment looks at your BMI, any weight-related health conditions, and your medical history to ensure treatment is both appropriate and safe for you. Two routes exist: NHS specialist services and regulated private providers. Both require a genuine clinical review before a prescription is issued.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Most people who research Wegovy reach the same wall: lots of information about what it does, very little about the practical steps to get it. So here's the honest version. Because semaglutide is a prescription-only medicine regulated by the MHRA, the process always starts with a qualified prescriber reviewing your case, your BMI, your health history, any medicines you already take. No shortcut around that step exists legally.
The Wegovy overview page covers how the medicine works in detail, but for the purposes of getting prescribed: what you'll need to show is that your BMI sits at 30 or above, or at 27 or above if you have at least one weight-related condition. Lower BMI thresholds apply for some ethnic backgrounds under UK clinical guidance. A prescriber then weighs up the full picture (contraindications, current medications, any conditions that would rule out semaglutide) before issuing a prescription. That review is not a formality; it's the point of the process.
One quick thing worth doing before you go further: search the GPhC pharmacy register at pharmacyregulation.org/registers to confirm any online pharmacy you're considering is properly registered. Takes under a minute and tells you immediately whether a provider is operating within the law.
NICE recommended semaglutide (Wegovy) for NHS use in 2023, under guidance TA875. The criteria are specific: a BMI of 35 or above (or 30 to 34.9 in certain circumstances), at least one weight-related comorbidity, and access through a specialist weight management service that provides multidisciplinary support alongside the medicine. NICE also sets a maximum treatment duration of two years on the NHS.
In practice, NHS access involves a GP referral to a specialist service, which then assesses eligibility. Waiting lists at those services are often lengthy. The treatment itself is provided as part of a structured programme, diet support, activity coaching and clinical monitoring run alongside the medicine. If you're considering this route, your GP is the starting point; they can advise on local referral pathways and realistic timescales.
It's worth knowing that the rules differ slightly across the UK. Scotland, Wales and Northern Ireland apply their own commissioning criteria, so thresholds and waiting times vary by nation. For a broader picture of how and when Wegovy tends to be prescribed through NHS channels, the when Wegovy is prescribed page sets out the different scenarios clearly.
A regulated private provider follows the same clinical steps as an NHS service, the prescription is no less rigorous, just faster and without a referral. At nume, every consultation is read by a GPhC-registered Independent Prescriber the same day. Not software. A named clinician reviews your answers, checks your eligibility against the licensed criteria, and only issues a prescription if treatment is clinically appropriate. Photo ID and live weight verification are part of that process, as is GP notification in line with GPhC guidance.
Once approved, treatment is dispatched the same day for free next-working-day delivery via DPD, plain packaging, tracked. The consultation itself is free, as is the prescription and delivery. There's no subscription and no auto-renewal; every repeat order goes back through clinical review before anything is sent. If you want to understand what that single transparent price covers, the Wegovy price comparison page gives an honest breakdown of what different providers typically include and what they sometimes don't.
For anyone wondering whether getting prescribed semaglutide through a private online pharmacy is a legitimate route, the short answer is yes, provided the pharmacy is GPhC-registered and the prescription comes from a qualified prescriber. Our page on how to get prescribed semaglutide walks through exactly what the process involves at each stage, if you'd like the full picture before starting. You can also read more about the specifics of how to be prescribed Wegovy if you want the detailed step-by-step.
A prescriber will look for contraindications as carefully as they look for eligibility. Wegovy is not recommended during pregnancy, while breastfeeding, or if you're trying to conceive. It's not licensed for under-18s. A personal or family history of medullary thyroid carcinoma or MEN2, a history of pancreatitis, or certain gastrointestinal conditions will prompt a careful discussion or rule out treatment. Some medicines interact with semaglutide in ways that matter clinically.
None of this means you won't qualify, it means the assessment exists for a reason. The NHS describes the common side effects (mostly gastrointestinal: nausea, indigestion, changes in bowel habits, occasional fatigue) on the NHS semaglutide medicines page, and reading it before your consultation is genuinely useful preparation. You'll go in knowing what questions to ask.
If you've been on semaglutide elsewhere and want to transfer your prescription, or if you're unsure whether you meet the eligibility criteria, the free consultation at nume is the sensible next step. A prescriber will review your situation and tell you plainly where you stand, no obligation, no pressure. If you're also curious about the commercial side of the medicine, our page covering the Wegovy stock symbol looks at how Novo Nordisk's investment case has developed alongside the drug's clinical rollout.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.